File Download

There are no files associated with this item.

Supplementary

Conference Paper: Serum thrombospondin-2 level as a novel liver fibrosis biomarker that changes with liver stiffness improvement in patients with type 2 diabetes. American Diabetes Association 83rd Scientific Sessions, San Diego, June 2023

TitleSerum thrombospondin-2 level as a novel liver fibrosis biomarker that changes with liver stiffness improvement in patients with type 2 diabetes. American Diabetes Association 83rd Scientific Sessions, San Diego, June 2023
Authors
Mak, JHFong, CHWong, YTan, KCLam, KSLee, CH
Issue Date23-Jun-2023
Persistent Identifierhttp://hdl.handle.net/10722/337269

 

DC FieldValueLanguage
dc.contributor.authorMak, JH-
dc.contributor.authorFong, CH-
dc.contributor.authorWong, Y-
dc.contributor.authorTan, KC-
dc.contributor.authorLam, KS-
dc.contributor.authorLee, CH-
dc.date.accessioned2024-03-11T10:19:23Z-
dc.date.available2024-03-11T10:19:23Z-
dc.date.issued2023-06-23-
dc.identifier.urihttp://hdl.handle.net/10722/337269-
dc.languageeng-
dc.relation.ispartofAmerican Diabetes Association 83rd Scientific Sessions (23/06/2023-26/06/2023, San Diego)-
dc.titleSerum thrombospondin-2 level as a novel liver fibrosis biomarker that changes with liver stiffness improvement in patients with type 2 diabetes. American Diabetes Association 83rd Scientific Sessions, San Diego, June 2023-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats